InvestorsHub Logo
icon url

misiu143

01/02/19 6:27 AM

#32638 RE: Emergcy #32637

IMO it is not a terrible medicine , yes many serious side effects but when no other choice I am sure it saved some life’s .
I will say all drugs are with some serious side effects , what we see with Leronlimab is very unusual ..

icon url

Inoviorulez

01/02/19 2:19 PM

#32652 RE: Emergcy #32637

To be fair the problem right now with CYDY is money. It needs cash to finish filing the BLA in Q1 2019. AbbVie is loaded with cash and can get filings and products approved easily. Plus AbbVie has more experience with drug approvals since it has been doing it so long.